Vaccine data
The FDA has released its briefing document and Pfizer’s briefing document for their external advisory committee meeting on Friday. Lots and lots of lovely detail.
Useful summaries and interpretations (I’ll add more as I come across them):
- Twitter thread from Hilda Bastian
- Washington Post
- NY Times
- Derek Lowe (this reads as more positive about side effects, but that’s because he’s primarily asking are the data good enough for emergency authorisation?)
You can watch the FDA advisory committee meeting, from 4am to 1pm Friday morning NZ time, and I assume there will be a recording available afterwards. It will be very boring, but transparency is like that.
PS: there is also a new publication from the Oxford group about some of the Oxford/AstraZeneca trials. It’s not really going to make anyone happy.
PPS: Next week, the FDA does the Moderna vaccine, but that’s less interesting for NZ since we didn’t buy any.
Thomas Lumley (@tslumley) is Professor of Biostatistics at the University of Auckland. His research interests include semiparametric models, survey sampling, statistical computing, foundations of statistics, and whatever methodological problems his medical collaborators come up with. He also blogs at Biased and Inefficient See all posts by Thomas Lumley »